| Literature DB >> 25487353 |
Jo Kåre Herfjord, Torhild Heggestad, Håkon Ersland, Anette Hylen Ranhoff1.
Abstract
BACKGROUND: Intermediate care is intended to reduce hospital admissions and facilitate early discharge. In Norway, a model was developed with transfer to intermediate care shortly after hospital admission. Efficacy and safety of this model have not been studied previously.In a parallel-group randomized controlled trial, patients over 70 years living at home before admission were eligible if clinically stable, without need for surgical treatment and deemed suited for intermediate care by attending physician. Intervention group patients were transferred to a nursing home unit with increased staff and multidisciplinary assessment, for a maximum stay of three weeks. Patients in the control group received usual care in hospital. Blinding to group assignment was not possible.The primary outcome was number of days living at home in a follow-up period of 365 days. Secondary outcomes were mortality, hospital admissions, need for residential care and home care services. Data were obtained from patient records and registers.Entities:
Mesh:
Year: 2014 PMID: 25487353 PMCID: PMC4295396 DOI: 10.1186/1756-0500-7-889
Source DB: PubMed Journal: BMC Res Notes ISSN: 1756-0500
Baseline characteristics
| Control group | Intervention group | p-value | |
|---|---|---|---|
| Number of patients | |||
| all patients | 186 | 190 | |
| medical patients | 72 (38.7 %) | 78 (41.1 %) | |
| orthopedic patients | 68 (36.6 %) | 60 (31.6 %) | |
| other | 46 (24.7 %) | 52 (27.3 %) | |
| Age, mean and range | |||
| all patients | 84.6 (71–98) | 83.6 (70–96) | |
| medical patients | 85.2 (72–98) | 83.9 (70–96) | |
| orthopedic patients | 83.9 (71–95) | 84.0 (70–95) | |
| Proportion of females | |||
| all patients | 73.7 % | 73.2 % | |
| medical patients | 61.1 % | 61.5 % | |
| orthopedic patients | 82.4 % | 85.0 % | |
| Proportion of patients with home health care | |||
| all patients | 53.2 % | 48.9 % | 0.47 |
| medical patients | 58.3 % | 43.6 % | 0.52 |
| orthopedic patients | 52.9 % | 60.0 % | 0.53 |
| Barthel ADL Index score, mean and range | |||
| all patients | 70.0 (0–100) | ||
| medical patients | 80.0 (35–100) | ||
| orthopedic patients | 56.7 (0–100) |
Figure 1Participant flow.
Results
| Control group | Intervention group | p-value | Relative risk | Confidence interval | Relative effect size | Absolute effect size | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mean | Range | SD | Mean | Range | SD | ||||||
| Days living home | |||||||||||
| all patients | 256.5 | 0-364 | 125.1 | 253.7 | 0-359 | 120.4 | 0.80 | ÷ 1.1 % | ÷ 2.8 days | ||
| medical patients | 250.4 | 0-364 | 134.1 | 249.2 | 0-359 | 123.6 | 0.165 | ÷ 0.5 % | ÷ 1.2 days | ||
| orthopedic patients | 256.5 | 0-364 | 121.0 | 233.2 | 0-357 | 128.2 | 0.09 | ÷ 9.1 % | ÷ 23.3 days | ||
| Days in nursing home | |||||||||||
| all patients | 55.0 | 0-360 | 91.7 | 40.6 | 0-344 | 71.4 | 0.046 | ÷ 26.1 % | ÷ 14.4 days | ||
| medical patients | 44.1 | 0-360 | 86.5 | 37.8 | 0-344 | 62.9 | 0.876 | ÷ 14.3 % | ÷ 6.3 days | ||
| orthopedic patients | 74.7 | 0-360 | 106.0 | 49.5 | 0-343 | 81.6 | 0.192 | ÷ 33.7 % | ÷ 25.2 days | ||
| Days in hospital | |||||||||||
| all patients | 10.5 | 0-72 | 15.2 | 10.4 | 0-92 | 15.8 | 0.748 | ÷ 0.01 % | ÷ 0.1 days | ||
| medical patients | 12.9 | 0-72 | 17.2 | 10.6 | 0-70 | 14.9 | 0.530 | ÷18.1 % | ÷ 2.3 days | ||
| orthopedic patients | 8.2 | 0-61 | 12.7 | 12.0 | 0-92 | 19.0 | 0.536 | + 46.6 % | + 3.8 days | ||
| One-year mortality | |||||||||||
| all patients | 17.2 % | 22.1 % | 0.29 | 1.29 | 0.85–1.94 | + 28.5 % | + 4.9 % | ||||
| medical patients | 25.0 % | 25.6 % | 0.99 | 1.03 | 0.59–1.78 | + 2.4 % | + 0.6 % | ||||
| orthopedic patients | 10.3 % | 25.0 % | 0.049 | 2.43 | 1.05–5.55 | + 142.7 % | + 14.7 % | ||||
| No home health care | |||||||||||
| all patients | 19.9 % | 31.6 % | 0.007 | 1.59 | 1.11–2.27 | + 58.8 % | + 11.7 % | ||||
| medical patients | 18.1 % | 35.9 % | 0.011 | 1.99 | 1.12–3.53 | + 98.6 % | + 17.8 % | ||||
| orthopedic patients | 19.1 % | 30.0 % | 0.219 | 1.57 | 0.84–2.93 | + 57.1 % | + 10.9 % | ||||
Figure 2Distribution of endpoints in different subgroups in the 365 days follow-up period (mean values).